FOXP3 and breast carcinoma: A multivariate analysis with adjustment for patient age and human epidermal growth factor receptor 2 status demonstrated significantly poor survival of FOXP3-strong-positive patients in node-positive patients, which suggest that this protein expression in breast cancer cells is associated with poor prognosis [32].